Sacituzumab Govitecan plus Pembrolizumab in 1L Metastatic Non-Small Cell Lung Cancer: Preliminary Results of the EVOKE-2 Study

被引：0

作者：

Patel, Jyoti ^{[1
]}

Cho, Byoung Chul ^{[2
]}

Dols, Manuel Cobo ^{[3
]}

Cabanillas, Roxanna Reyes ^{[4
]}

Baz, David Vicente ^{[5
]}

Pradera, Jose Fuentes ^{[6
]}

Grisanti, Salvatore ^{[7
]}

Gabayan, Afshin E. ^{[8
]}

Lee, Ki Hyeong ^{[9
]}

Cho, Eun Kyung ^{[10
]}

Mekan, Sabeen Fatima ^{[11
]}

Safavi, Farnoush ^{[11
]}

Fernando, Nalumka ^{[11
]}

Chisamore, Michael J. ^{[12
]}

Recki, Martin ^{[13
]}

机构：

[1] Robert H Lurie Comprehens Canc Ctr, Northwestern Med, Chicago, IL USA

[2] Yonsei Univ, Yonsei Canc Ctr, Coll Med, Seoul, South Korea

[3] Reg & Virgen Victoria Univ Hosp, IBIMA, Malaga, Spain

[4] Hosp Clin Barcelona, Barcelona, Spain

[5] Hosp Univ Virgen Macarena, Seville, Spain

[6] Hosp Univ Virgen Valme, Seville, Spain

[7] ASST Spedali Civili Brescia, Brescia, Italy

[8] Beverly Hills Canc Ctr, Beverly Hills, CA USA

[9] Chungbuk Natl Univ Hosp, Cheongju, Chungbuk, South Korea

[10] Gachon Univ, Gil Med Ctr, Incheon, South Korea

[11] Gilead Sci Inc, Foster City, CA USA

[12] Merck & Co Inc, Rahway, NJ USA

[13] German Ctr Lung Res DZL, Airway Res Ctr North, LungenClin, Grosshansdorf, Germany

来源：

JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 07期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

PPD01.06

引用

页码：E6 / E7

页数：2

共 50 条

[41] Pembrolizumab plus allogeneic NK cells in advanced non-small cell lung cancer patients
Lin, Mao
Luo, Haihua
Liang, Shuzhen
Chen, Jibing
Liu, Aihua
Niu, Lizhi
Jiang, Yong
JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (05): : 2560 - 2569
[42] Patterns of Failure in Metastatic Non-Small Cell Lung Cancer Patients After Initiation of Pembrolizumab
All, S.
Iyengar, P.
Westover, K. D.
Choy, H.
Rashdan, S.
Lohrey, J.
Hughes, R.
Dowell, J.
Gerber, D. E.
Vo, D. T.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E420 - E420
[43] Evan's Syndrome Associated with Pembrolizumab Therapy in Metastatic Non-Small Cell Lung Cancer
Lott, Anthony
Butler, Marcus
Leigh, Natasha
Cserti-Cazdewich, Christine M.
BLOOD, 2015, 126 (23)
[44] ENCEPHALOPATHY FOLLOWING TREATMENT WITH PEMBROLIZUMAB FOR METASTATIC NON-SMALL CELL LUNG CANCER: A CASE REPORT
Feng, S.
O'Byrne, K.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 54 - 54
[45] Preliminary results from phase Ib study of spartalizumab plus chemotherapy for advanced non-small cell lung cancer (NSCLC)
Santoro, A.
Garrido Lopez, P.
Tan, D. S. W.
Paz-Ares, L.
Shepherd, F.
Bearz, A.
Barlesi, F.
Vansteenkiste, J. F.
Kim, T. M.
Overbeck, T. R.
Rybkin, I. I.
Felip, E.
Zhou, W.
Santarpia, L.
Eddy, S.
Schaefer, E. S.
ANNALS OF ONCOLOGY, 2019, 30
[46] A retrospective analysis of pembrolizumab plus chemotherapy versus pembrolizumab monotherapy for advanced or recurrent non-small cell lung cancer
Isono, Taisuke
Kagiyama, Naho
Shibata, Shun
Nakajima, Hitomi
Matsui, Yuma
Takano, Kenji
Nishida, Takashi
Hosoda, Chiaki
Kawate, Eriko
Kobayashi, Yoichi
Ishiguro, Takashi
Takaku, Yotaro
Kurashima, Kazuyoshi
Yanagisawa, Tsutomu
Takayanagi, Noboru
THORACIC CANCER, 2021, 12 (09) : 1387 - 1397
[47] VELOCITY-Lung: A phase (Ph) 2 study evaluating safety and efficacy of domvanalimab (dom) plus zimberelimab (zim) plus sacituzumab govitecan (SG), or etrumadenant (etruma) plus dom plus zim, or etruma plus zim in patients (pts) with treatment-naive metastatic non-small cell lung cancer (mNSCLC).
Spira, Alexander I.
Chiu, Joanne
Wang, Chin Chou
Zer, Alona
Conibear, John
Phuong, Patrick Hoang
Park, Joseph K.
Seto, Anna
Zhang, Jie
Cho, Byoung Chul
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[48] Epacadostat Plus Pembrolizumab in Patients with Non-Small Cell Lung Cancer: Phase 1/2 Results from ECHO-202/KEYNOTE-037
Villaruz, L.
Schneider, B.
Bauer, T.
Spira, A.
D'Amato, G.
Wasser, J.
Balmanoukian, A.
Lara, P.
Olszanski, A.
Gajewski, T.
Patel, S.
Tarhini, A.
Bauml, J.
Schmidt, E.
Bowman, J.
Daniel, J.
Owens, S.
Mitchell, T.
JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S330 - S330
[49] Therapy of metastatic, non-small cell lung cancer (mNSCLC) with the anti-Trop-2-SN-38 antibody-drug conjugate (ADC), sacituzumab govitecan (IMMU-132).
Camidge, D. Ross
Heist, Rebecca Suk
Masters, Gregory A.
Scheff, Ronald J.
Starodub, Alexander
Messersmith, Wells A.
Bardia, Aditya
Ocean, Allyson J.
Horn, Leora
Berlin, Jordan
Maliakal, Pius P.
Sharkey, Robert M.
Wilhelm, Francois
Goldenberg, David M.
Guarino, Michael J.
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[50] Preliminary results of induction chemotherapy plus chemoradiotherapy in patients with locally advanced non-small cell lung cancer
Kocak, M.
Mayadagli, A.
Ozkan, A.
Gul, S. K.
Parlak, C.
Oruc, F.
Yaprak, G.
Tepetam, H.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)

← 1 2 3 4 5 →